Biorem Inc. (BRM.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 91 | 95 | 133 | 109 | 134 |
| Income taxes - deferred | 71 | -88 | 417 | 267 | 15 |
| Accounts receivable | 3,527 | -3,314 | 189 | -3,046 | 5,526 |
| Accounts payable and accrued liabilities | -3,497 | 3,962 | 848 | 391 | -1,072 |
| Other Working Capital | -1,524 | 507 | -808 | -2,513 | 4,451 |
| Other Operating Activity | 203 | 2,217 | 122 | 3,455 | -4,359 |
| Operating Cash Flow | $-1,129 | $3,378 | $901 | $-1,336 | $4,695 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -271 | -28 | 0 | -249 | -91 |
| Investing Cash Flow | $-271 | $-28 | $0 | $-249 | $-91 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -185 | -145 | -144 | -187 | -206 |
| Other Financing Activity | 0 | 16 | -100 | 0 | 0 |
| Financing Cash Flow | $-185 | $-130 | $-244 | $-187 | $-206 |
| Exchange Rate Effect | 71 | -66 | 37 | -172 | -11 |
| Beginning Cash Position | 11,505 | 8,350 | 7,655 | 9,600 | 5,213 |
| End Cash Position | 9,990 | 11,505 | 8,350 | 7,655 | 9,600 |
| Net Cash Flow | $-1,586 | $3,220 | $658 | $-1,772 | $4,398 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,129 | 3,378 | 901 | -1,336 | 4,695 |
| Capital Expenditure | -271 | -28 | N/A | -249 | -91 |
| Free Cash Flow | -1,401 | 3,350 | 901 | -1,585 | 4,604 |